Thiazoline and phthalimides derivatives as Mycobacterium tuberculosis MurB inhibitors: A molecular docking study

Vol 2, 2022 - 153243
Poster
Favorite this paper
How to cite this paper?
Abstract

The development of resistant strains of Mycobacterium tuberculosis (Mtb) is a big concern, which highlights the need of discovering new antibiotics1. Recent studies investigated molecular targets in earlier steps of peptidoglycan synthesis to discover new drugs for tuberculosis treatment2. These findings led us to select the enzyme UDP-N-acetylenolpyruvoylglucosamine reductase (MurB) due to its essential role in peptidoglycan synthesis and no eukaryote homologue2. Andres and coworkers discovered 4-thiazolidinones as MurB inhibitors at a micromolar level3. This way, we are proposing thiazoline and phthalimide derivatives as MurB inhibitors. Molecular docking studies were performed with MurB4 in complex with the proposed heterocycles with several aromatic substituents (electronic and steric effects) and their precursors, which resulted in more than 150 molecules. Interactions with key residues in MurB catalysis such as Arg176, Glu361 and Ser257 were observed, also theoretical Ki at low micromolar range. These results may guide the discovery of new antibiotics against Mtb.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Agreste Academic Centre, Universidade Federal de Pernambuco - UFPE
  • 2 Department of Fundamental Chemistry, Universidade Federal de Pernambuco - UFPE
Track
  • 1. Strategies in Drug Design
Keywords
Drug Discovery
heterocyclic chemistry
Tuberculosis
antimicrobial agents